In this exploratory work, we have examined the impact of an external static electric field on the H2 storage capacity of clathrate hydrates. To this end, we have chosen the 512 clathrate hydrate and examined the encapsulation of 1 - 4 H2 molecules within it. Results suggest that with the help of moderate electric fields (±0.10 to ±0.31V/Å), the encapsulation of 1 H2 molecule within the 512 clathrate hydrate becomes thermodynamically more favorable. In the cases of 4H2@512 and 2H2@512, however, the concerned processes become thermodynamically more favorable only when the field is applied along a specific direction. No favorable outcome could be observed in the case of 3H2@512, irrespective of the direction of the applied field. It appears from the results obtained herein that it might be possible to design a suitable external electric field to facilitate the hydrogen storage capacity of clathrate hydrates at ambient conditions, at least in certain cases.

Background: Bacterial infections constantly have a large impact on public health, because of increased rates of resistance and reduced frequency of development of novel antibiotics. The utility of conventional antibiotics for treating bacterial infections has become increasingly challenging. The aim of the study was to assess the antibacterial effect of β -Lapachone, a novel synthetic compound. Methods: The antibacterial activity of the β -Lapachone compound was examined against laboratory strains by agar well diffusion method, minimal inhibitory concentration (MICs), and minimal bactericidal concentration (MBCs). Growth kinetics inhibition in presence of β -Lapachone on Staphylococcus aureus, Staphylococcus epidermidis and Pseudomonas aeruginosa (ATCC 27853) was assessed by MABA. Crystal violet blue assay was used for biofilm inhibition assays, biofilm eradication assay and for molecular modeling PyMOL was used. Results: β -Lapachone exhibited potent antimicrobial activity against laboratory strains of bacteria with MIC of 0.2 mM for S. saprophyticus and Staphylococcus aureus, and 0.04 mM for Staphylococcus epidermidis and Pseudomonas aeruginosa ATCC 27853. The inhibition of catalase enzyme was found to be the cause for its antibacterial activity. Molecular modeling predicted the binding of β -Lap at active site and heme binding site of catalase, KatA. The activity of some commercial antibiotics was enhanced in association with β -Lap. In addition, β -Lap inhibited the biofilm formation and eradicated the already formed and ultra-mature biofilms of aforesaid bacterial strains.